Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? EQUITY (Details Narrative)

v3.21.2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 1 Months Ended 9 Months Ended
Jan. 12, 2021
Jan. 06, 2021
Jan. 04, 2021
Jan. 02, 2018
Aug. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Proceeds from public offering     $ 2,300,000        
Share based compensation non vested shares           95,179  
Number of options, exercises in period           25,000  
Stock based compensation expense           $ 152,335,353 $ 1,032,199
December Thirty One Two Thousand Twenty One [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Stock based compensation expense           642,789  
March Thirty One Two Thousand Twenty Two [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Stock based compensation expense           232,241  
June Thirty Two Thousand Twenty Two [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Stock based compensation expense           $ 2,533  
Stock Options [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of options, exercises in period           23,500  
Warrant [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Number of warrants issued           172,948  
Securities Purchase Agreement [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Sale of stock 12,500,000            
Securities Purchase Agreement [Member] | Certain Purchasers [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Sale of stock 12,500,000            
Shares issued price $ 20.00            
Proceeds from public offering $ 250,000,000            
Letter Agreement [Member] | H.C. Wainwright & Co., LLC [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Fee payment description         The Company also issued to designees of the Placement Agent warrants to purchase up to 3.0% of the aggregate number of shares of Common Stock sold in the transactions, or warrants to purchase up to 375,000 shares of Common Stock (the “Placement Agent Warrants”). The Placement Agent Warrants have an exercise price equal to 125% of the offering price per share (or $25.00 per share). The Company also agreed to pay the Placement Agent $50,000 for accountable expenses, to reimburse an investor’s legal fees in an amount up to $7,500 and to pay $12,900 for the Placement Agent’s clearing fees. Pursuant to the terms of the Engagement Letter, the Placement Agent has the right, for a period of twelve months following the closing of the Offerings, to act (i) as financial advisor in connection with any merger, consolidation or similar business combination by the Company and (ii) as sole book-running manager, sole underwriter or sole placement agent in connection with certain debt and equity financing transactions by the Company.    
Warrant to purchase common stock         375,000    
Warrant exercise price         $ 25.00    
Accountable expense         $ 50,000    
Legal fees         7,500    
Agent clearance fees         $ 12,900    
2018 Equity Incentive Plan [Member]              
Accumulated Other Comprehensive Income (Loss) [Line Items]              
Common stock shares issued during period       625,000      
Share based compensation non vested shares   566,279